Institut National d'Oncologie

Decentralized homologous recombination deficiency (HRD) testing in advanced high-grade serous ovarian carcinoma: real-world implementation and molecular profiling from Morocco

Abstract Background Homologous Recombination Deficiency (HRD) testing guides poly (ADP-ribose) polymerase inhibitor (PARPi) therapy in high-grade serous ovarian carcinoma (HGSOC). Centralized commercial assays pose logistical and financial barriers in low- and middle-income count...